NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: BASF

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BASF Aroma Ingredients Expands its Isobionics® Portfolio with New Natural Flavors - Isobionics®, a brand of BASF Aroma Ingredients, is launching two new natural products on the flavor market - BASF.com
BASF Aroma Ingredients Expands its Isobionics® Portfolio with New Natural Flavors

 

NewswireTODAY - /newswire/ - Geleen, Netherlands, 2023/10/30 - Isobionics®, a brand of BASF Aroma Ingredients, is launching two new natural products on the flavor market - BASF.com. Frankfurt (BAS)

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Isobionics® Natural alpha-Bisabolene 98 and Isobionics® Natural (-)-alpha-Bisabolol 99 are the latest additions to Isobionics' flavor portfolio;
• New flavors were developed following requests and valuable feedback from our customers, which is the core of our strategy and commitment to the natural flavor business.

Isobionics® Natural alpha-Bisabolene 98 and Isobionics® Natural (-)-alpha-Bisabolol 99 are the latest additions to our Isobionics' portfolio being proof points of our commitment to developing natural flavors driven by customer needs.

"We are delighted to introduce the two new products, which are natural flavors and produced with our cutting-edge fermentation technology. Therefore, they are independent from harvest conditions and pesticide free," says Toine Janssen, CEO of Isobionics®. "This is a major milestone for us and for the flavor industry, as it is the first time that two natural flavors are being launched and marketed together. Building on our cutting-edge fermentation technology we can constantly expand our natural flavor portfolio beyond our well-established citrus products to address further customer and market demands."

Breaking new ground beyond the citrus portfolio, Isobionics® is unlocking a world with new possibilities for food, beverage, and flavor enthusiasts and is proud to introduce the following two products:

I• sobionics® Natural (-)-alpha-Bisabolol is a known product, traditionally derived from natural sources and with a complex and captivating aroma profile. Renowned for its delicate floral notes, it offers a subtle hint of chamomile, along with hints of sweet, woody undertones, resulting in a truly unique flavor experience. This groundbreaking innovation allows culinary professionals and beverage creators to boost other flavors such as Vanillin and Nootkatone to add a distinctive twist to their creations.
• Isobionics® Natural alpha-Bisabolene 98 is a breakthrough in the flavor industry as its purity improves better flavor development. Moreover, with its creamy milky flavor, it makes a major contribution to the expansion of the Isobionics®' portfolio.

Our new flavors expand the flavorist palette to a new level

One of the most exciting aspects of the two new flavor ingredients is their great versatility. These flavor ingredients, produced at very high concentration via fermentation technology can be found not only in citrus essential oils, but also in several other natural oils, such as chamomile, ylang-ylang, black pepper, and basil oils. The very high quality of our natural flavors opens a world of possibilities for flavor enhancement in a variety of applications. Whether it is adding crispness to mild flavors, complexity to your beverages and confectionery formulations, or a savory punch to culinary creations, the new products offer limitless potential for creating memorable taste experiences. These natural products, use only renewable raw materials and they are produced via fermentation technology, which makes them independent from harvest conditions and seasonality and free from agricultural residues, thus ensuring a constant quality in your products.

Steffen Götz, Vice President of Aroma Ingredients at BASF, highlights the dedication to customer-centric innovation: "Isobionics' new flavor solutions embody our ongoing commitment to providing sustainable and high-quality ingredients. These new product launches complement and expand the existing portfolio and answer the need for fermentation-based natural flavors. Dedication to providing natural and sustainable flavor solutions forms the core of our new product developments. Our biotech platform plays a significant role in developing future ingredients to deliver exceptional flavor profiles that are geared to consumer preferences."

The new natural flavors Isobionics® Natural alpha-Bisabolene 98 and Isobionics® Natural (-)-alpha-Bisabolol 99 have now been officially launched. Customers can already reach out to their designated sales contact and schedule an exclusive presentation of the new flavors to experience these extraordinary flavor innovations firsthand.

About BASF’s Nutrition & Health division

BASF Nutrition & Health (basf.com) provides a comprehensive product and service range for human and animal nutrition, pharmaceutical, and flavor & fragrance industries. With our science-driven portfolio, we address customers in globally growing markets to meet the demands of an expanding world population. Together with our customers, we play an active role in enhancing the nutrition, health and wellbeing of consumers all over the world. Our products fulfill the highest safety, regulatory and sustainability standards. BASF Nutrition & Health operates sites in Europe, North America and in Asia-Pacific.

About BASF

At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. More than 111,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €87.3 billion in 2022. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: BASF

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BASF Aroma Ingredients Expands its Isobionics® Portfolio with New Natural Flavors

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Isobionics® | BASF’s Nutrition & Health
Contact: Rebekka-Martina Müller - BASF.com 
+49 151 655 700 69 rebekka-martina.mueller@partners.basf.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any BASF securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From BASF / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen’s Onivyde® Regimen, A Potential New Standard-of-care First-line Therapy in Metastatic Pancreatic Adenocarcinoma, Approved by FDA
Frost & Sullivan and Trautec have Conducted An Extensive Investigation Across the Recombinant Type XVII Collagen Industry Chain
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
Bushu Pharma Recognized with Frost & Sullivan’s 2023 Japan Customer Value Leadership Award for Offering Advanced Pharmaceutical Manufacturing
STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award
BASF Pharma Solutions and IFF Pharma Solutions Establish Collaboration on Virtual Pharma Assistant Platform ZoomLab™
BASF Invests in Start-up 3Helix, Inc. to Jointly Bring Collagen-hybridizing Peptide Solutions to the Personal Care Market
Thales and Bertin Partner in CBRN Defence with Successful Tests of Biological Sampling and Identification for the PIABC PELICAN
Ipsen Updates on E.U. Marketing Authorisation Application for Odevixibat in Alagille Syndrome
BASF Pharma Solutions Introduces 'VPA Premium Services' to its Virtual Pharma Assistants (VPAs) Digital Services Platform
NEC Selected by AMED for Design of A Universal Vaccine that is Effective Against Influenza Virus Strains
BostonGene, NEC and JIP Form Joint Venture in Japan
Exelixis and Ipsen Announce Positive Results from Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib
US FDA Approves Ipsen’s Sohonos™ (palovarotene) Capsules, the First and Only Treatment for People with Fibrodysplasia Ossificans Progressiva
SCHOTT Pharma Strengthens Leading Position in the First Year as Stand-alone Company

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  BizJobs.com





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)